3.82
price down icon4.02%   -0.16
after-market 시간 외 거래: 3.85 0.03 +0.79%
loading
전일 마감가:
$3.98
열려 있는:
$3.9
하루 거래량:
117.15K
Relative Volume:
0.76
시가총액:
$41.25M
수익:
-
순이익/손실:
$-19.25M
주가수익비율:
-2.1461
EPS:
-1.78
순현금흐름:
$-17.87M
1주 성능:
-1.80%
1개월 성능:
-15.86%
6개월 성능:
+9.46%
1년 성능:
+9.46%
1일 변동 폭
Value
$3.75
$3.95
1주일 범위
Value
$3.70
$4.28
52주 변동 폭
Value
$2.55
$6.118

Lantern Pharma Inc Stock (LTRN) Company Profile

Name
명칭
Lantern Pharma Inc
Name
전화
972-277-1136
Name
주소
1920 MCKINNEY AVENUE, DALLAS, TX
Name
직원
24
Name
트위터
@lanternpharma
Name
다음 수익 날짜
2025-08-08
Name
최신 SEC 제출 서류
Name
LTRN's Discussions on Twitter

LTRN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
LTRN
Lantern Pharma Inc
3.82 42.98M 0 -19.25M -17.87M -1.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
417.21 108.30B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
652.91 69.37B 14.25B 4.58B 3.56B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.59 62.38B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
821.97 51.50B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
166.95 34.94B 398.11M -1.03B -868.57M -5.7032

Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-10-07 개시 H.C. Wainwright Buy

Lantern Pharma Inc 주식(LTRN)의 최신 뉴스

pulisher
Oct 29, 2025

How Lantern Pharma Inc. stock reacts to oil pricesWeekly Loss Report & Safe Capital Growth Tips - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers. - BioSpace

Oct 29, 2025
pulisher
Oct 28, 2025

Lantern Pharma (NASDAQ: LTRN) Reports Complete Metabolic Response in Phase 1 LP-284 Trial at LL&M Congress - Digital Journal

Oct 28, 2025
pulisher
Oct 28, 2025

Will Lantern Pharma Inc. stock recover after recent dropWeekly Risk Report & Growth-Oriented Investment Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Using economic indicators to assess Lantern Pharma Inc. potentialIPO Watch & Target Return Focused Picks - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Lantern Pharma (LTRN) Reports Promising Phase 1 Trial Results fo - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Lantern Pharma presents LP-284 clinical data at 25th LL&M Congress - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Is Lantern Pharma Inc. stock attractive for income investorsInsider Selling & Weekly Return Optimization Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

What technical signals suggest for Lantern Pharma Inc. stockGDP Growth & Growth Focused Stock Pick Reports - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Is Lantern Pharma Inc. stock a buy before product launchesTrade Volume Summary & Advanced Technical Analysis Signals - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Lantern Pharma Inc. stock trendline breakdown2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Lantern Pharma Inc. stock maintain dividend yieldQuarterly Trade Summary & Real-Time Sentiment Analysis - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Why Lantern Pharma Inc. stock is favored by pension fundsTrade Exit Summary & Low Risk Profit Maximizing Plans - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Lantern Pharma’s Promising Phase II Lung Cancer Study: Key Insights for Investors - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Lantern Pharma’s LP-284 Study: A Potential Game-Changer in Cancer Treatment? - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Lantern Pharma’s LP-184 Study: A Potential Game-Changer in Cancer Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

When is the best time to exit Lantern Pharma Inc.July 2025 Price Swings & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025 - BioSpace

Oct 27, 2025
pulisher
Oct 26, 2025

How to interpret RSI for Lantern Pharma Inc. stock2025 Macro Impact & AI Forecasted Stock Moves - newser.com

Oct 26, 2025

Lantern Pharma Inc (LTRN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$36.67
price up icon 0.71%
$90.18
price down icon 1.60%
$28.95
price down icon 0.62%
$103.35
price down icon 1.60%
biotechnology ONC
$314.85
price down icon 0.63%
$166.95
price up icon 1.00%
자본화:     |  볼륨(24시간):